NEW YORK – Swift Biosciences and MGI Tech, a subsidiary of the BGI Group, said on Tuesday that they have signed an agreement to jointly market Swift's library preparation products in Europe and Asia Pacific.
Under the partnership, the companies will make Swift's library prep kits compatible with MGI's DNBSEQ sequencers, starting with the 2S Turbo DNA kit for whole-genome and targeted sequencing and the Rapid RNA and Methyl-Seq DNA Library kits.
"MGI is a valued partner and we will continue to grow the relationship," said Swift President and CEO Nathan Wood in a statement. "We have several exciting products launching this year and our R&D and manufacturing groups will be looking to enable the technology on the MGI platform as we continue our strategic worldwide growth."
MGI Chief Operating Officer Jiang Hui said in the statement that with this partnership, "MGI is demonstrating its commitment to continue opening its platform and bring more applications to our sequencing and grow our application community in order to support our customers."